BIPSO BIPSO GmbH covers the entire production chain for sterile contrast media supplying more than 100 countries worldwide. Discover more.

Bracco Imaging Earns Second Consecutive EcoVadis Platinum Medal with Record Sustainability Score Recognition reflects Bracco Imaging’s top-tier EcoVadis performance and strengthened sustainability data, governance and procurement practices.

Cell Therapy Built on Bracco’s lipid microbubble technology, BubbleGen™ enables simpler, bead-free, and column-free cell selection that integrates seamlessly into cell therapy research workflows.

BubbleGen Cell Selection Products Microbubble-based cell selection technology for cell therapy research.

BubbleGen CD3+ Cell Selection Kit The BubbleGen™ CD3+ Cell Selection Kit provides a ready-to-use solution for enrichment of CD3+ T cells using Bracco's BubbleGen™ microbubble technology.

BubbleGen Cell Separators The BubbleGen™ Cell Separators kit provides 10 cell separators to be used in conjunction with our BubbleGen™ cell selection kits.

Cell Therapy Resources Supporting successful implementation of BubbleGen™ workflows.

Celltherapy order form Order BubbleGen™ Cell Selection Research Products

Contact BubbleGen™ Support Every cell therapy research process is different. Partner with our team to identify how BubbleGen™ can help address your cell selection challenges and support your research program goals.

Major Global Milestone with U.S. FDA 510(k) Clearance and Health Canada Authorization for for VueJect®, the First Dedicated Ultrasound Contrast Delivery System VueJect® strengthens Bracco's integrated CEUS ecosystem by enabling more standardized, efficient contrast administration in cardiology imaging